SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF UnitsSAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF UnitsSAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF Units

SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF Units

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪7.15 B‬KRW
Fund flows (1Y)
‪−4.92 B‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−0.6%
Shares outstanding
‪700.00 K‬
Expense ratio
0.50%

About SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF Units


Brand
KoAct
Inception date
Sep 3, 2024
Management style
Active
Primary advisor
Samsung Active Asset Management Co., Ltd.
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Active
Geography
U.S.
Weighting scheme
Proprietary
Selection criteria
Proprietary

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of October 16, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.28%
Health Technology96.43%
Technology Services1.85%
Bonds, Cash & Other1.72%
Cash1.72%
Stock breakdown by region
81%18%
North America81.11%
Europe18.89%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


490330 invests in stocks. The fund's major sectors are Health Technology, with 96.43% stocks, and Technology Services, with 1.85% of the basket. The assets are mostly located in the North America region.
490330 top holdings are Biogen Inc. and uniQure N.V., occupying 13.59% and 5.95% of the portfolio correspondingly.
490330 assets under management is ‪7.15 B‬ KRW. It's risen 18.25% over the last month.
490330 fund flows account for ‪−4.92 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 490330 doesn't pay dividends to its holders.
490330 shares are issued by Samsung Life Insurance Co., Ltd. under the brand KoAct. The ETF was launched on Sep 3, 2024, and its management style is Active.
490330 expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
490330 invests in stocks.
490330 price has risen by 21.72% over the last month, and its yearly performance shows a 4.54% increase. See more dynamics on 490330 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 20.76% over the last month, showed a 19.87% increase in three-month performance and has decreased by −0.11% in a year.
490330 trades at a premium (0.16%) meaning the ETF is trading at a higher price than the calculated NAV.